Research programme: HIV vaccines - VIRxSYSAlternative Names: HIV gene therapy vaccine - VIRxSYS; VRX 1116; VRX1023; VRX1273
Latest Information Update: 20 Jul 2011
At a glance
- Originator VIRxSYS Corporation
- Class Gene therapies; Viral vaccines
- Mechanism of Action HIV envelope protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical HIV infections